A leadless intracardiac transcatheter pacing system has been designed to avoid the need for a pacemaker pocket and transvenous lead. It is probably going to be proved as the world’s smallest, minimally invasive pacemaker. For more than half a century, permanent cardiac pacing for symptomatic bradycardia has been achieved with systems that consist of a surgically implanted subcutaneous electrical generator connected to one or more transvenous leads that deliver the pacing therapy to the heart.
Although these devices are effective, approximately one in eight patients has an early complication, frequently related to the lead or leads or to the subcutaneous “pocket.” In a global clinical trial of a Transcatheter Pacing System (TPS), world’s smallest and least invasive cardiac pacing device, 719 out of 725 (99.2%) of the participants were successfully implanted with this device. There was no…
